Anal melanoma
- PMID: 20011314
- PMCID: PMC2780102
- DOI: 10.1055/s-2006-942348
Anal melanoma
Abstract
Anal melanoma is rare and aggressive malignancy. Patients commonly present with advanced, even metastatic disease. Unlike cutaneous melanoma, anal melanoma has no known risk factors. Surgical excision remains the cornerstone of therapy. There are no long-term survivors of stage II or III disease; therefore, early diagnosis and treatment remain crucial. There are no trials definitively proving abdominal perineal resection (APR) or wide local excision (WLE) to yield superior long-term survival. APR may offer a higher rate of local control, whereas WLE offers a much less morbid operation. Adjuvant chemotherapy, interferon, and radiation may offer some benefit.
Keywords: Melanoma; abdominoperineal resection; anal; malignancy; wide local excision.
References
-
- Roumen R MH. Anorectal melanoma in the Netherlands: a report of 63 patients. Eur J Surg Oncol. 1996;22:598–601. - PubMed
-
- Bullard K M, Tuttle T M, Rothenberger D A, et al. Surgical therapy for anorectal melanoma. J Am Coll Surg. 2003;196:206–211. - PubMed
-
- Molino D, Perrotti P, Antropoli C, et al. Primary anorectal melanoma. Chir Ital. 2000;52:329–334. - PubMed
-
- Chang A E, Karnell L H, Menck H R. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. Cancer. 1998;83:1664–1678. - PubMed
-
- Pack G T, Lenson N, Gerber D M. Regional distribution of moles and melanomas. Arch Surg. 1952;65:862–870. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
